Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.82 |
| ▸ | NPC1 | O15118 | 4/20 | 0.82 |
| ▸ | RAB9A | P51151 | 4/20 | 0.82 |
| ▸ | MAPT | P10636 | 4/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.82 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.82 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30612325 | 1.00 | ALDH1A1 (0.82) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL31037131 | 1.00 | ALDH1A1 (0.82) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL13338880 | 0.91 | KDM4E (0.67) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL30017661 | 0.91 | KDM4E (0.67) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL29372602 | 0.90 | ALDH1A1 (1.00) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL1880565 | 0.90 | ALDH1A1 (1.00) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL29359913 | 0.90 | ALDH1A1 (1.00) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL30567107 | 0.90 | ALDH1A1 (0.65) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL15318110 | 0.90 | ALDH1A1 (0.65) | ALDH1A1NPC1RAB9AMAPTKDM4E | |
| SCHEMBL13135135 | 0.84 | ALDH1A1 (0.64) | ALDH1A1NPC1RAB9AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9834740-B2 | Photoactivators | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-05 | — | — | US | claimed |
| EP-3097169-A1 | CONSUMER PRODUCT COMPOSITIONS | The Procter & Gamble Company (US) | 2016-11-30 | — | — | EP | claimed |
| EP-3097176-A1 | PHOTOACTIVATORS | The Procter & Gamble Company (US) | 2016-11-30 | — | — | EP | claimed |
| EP-3097168-A1 | SYSTEMS AND METHODS FOR TREATING A SURFACE | The Procter & Gamble Company (US) | 2016-11-30 | — | — | EP | claimed |
| US-20150210964-A1 | Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2015-07-30 | — | — | US | claimed |
| US-20150210963-A1 | Systems and Methods for Treating a Surface | THE PROCTER & GAMBLE COMPANY | 2015-07-30 | — | — | US | claimed |
| US-20150210960-A1 | Photoactivators | THE PROCTER & GAMBLE COMPANY | 2015-07-30 | — | — | US | claimed |
| WO-2015112671-A1 | CONSUMER PRODUCT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-07-30 | — | — | WO | claimed |
| WO-2015112675-A1 | PHOTOACTIVATORS | THE PROCTER & GAMBLE COMPANY (US) | 2015-07-30 | — | — | WO | claimed |
| WO-2015112667-A1 | SYSTEMS AND METHODS FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2015-07-30 | — | — | WO | claimed |
| EP-0962826-A1 | A positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-08 | — | — | EP | claimed |
| US-20260117083-A1 | ACTIVE ENERGY RAY-CURABLE INKJET BLACK INK AND PRINTED MATTER | ARTIENCE CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4733362-A1 | ACTIVE ENERGY RAY-CURABLE INKJET INK AND PRINTED MATTER | artience Co., Ltd. (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-3994125-B1 | MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF | REGENERON PHARMA (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2025108852-A1 | PROCESS FOR THE PREPARATION OF UNSATURATED ESTERS | BASF SE (DE) | 2025-05-30 | — | — | WO | disclosed |
| EP-1270568-A1 | 1-methyl-4-(3-ethoxy-9h-thioxanthene-ylidene)-piperidine and its use as 5-HT2B and/or H1 antagonist | Biofrontera Pharmaceuticals AG (DE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002102797-A1 | 1-METHYL-4-(3-ETHOXY-9H-THIOXANTHENE-9-YLIDENE)-PIPERIDINE AND ITS USE AS 5-HT2B AND/OR H1 ANTAGONIST | BIOFRONTERA AG (DE) | 2002-12-27 | — | — | WO | disclosed |
| US-6054501-A | CURABILITY; GLOSSINESS; CAN BE BLENDED WITH INKS, PAINTS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2000-04-25 | — | — | US | disclosed |
| EP-0962826-A1 | A positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-08 | — | — | EP | disclosed |
| EP-0844255-A1 | PHOTOPOLYMERIZATION INITIATOR AND ACTINIC RADIATION-CURABLE COMPOSITION COMPRISING THE SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1998-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117083-A1 | ACTIVE ENERGY RAY-CURABLE INKJET BLACK INK AND PRINTED MATTER | MAPRE2, MAPRE1, HDLBP | ALDH1A1 1414/4885NPC1 2099/4885RAB9A 2098/4885 |
| US-20150210960-A1 | Photoactivators | NQO1, TYR, CYP1A1 | ALDH1A1 78/4885NPC1 3452/4885RAB9A 716/4885 |
| US-20150210963-A1 | Systems and Methods for Treating a Surface | HMBS, PPOX, TTPA | ALDH1A1 1283/4885NPC1 3523/4885RAB9A 3573/4885 |
| US-20150210964-A1 | Consumer Product Compositions | NQO1, TYR, ETFA | ALDH1A1 27/4885NPC1 3810/4885RAB9A 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.